Pharma Reviews: Hurt by competition, price caps, drug firms turn to in-licencing

Among leading Indian companies that have signed such in-licensing deals are Sun Pharma, Lupin, Dr Reddy's Labs and Glenmark Pharma.
Read more: Hurt by competition, price caps, drug firms turn to in-licencing